Cargando…
BCL2 Family Inhibitors in the Biology and Treatment of Multiple Myeloma
Although much progress has been made in the treatment of multiple myeloma, the majority of patients fail to be cured and require numerous lines of therapy. Inhibitors of the BCL2 family represent an exciting new class of drugs with a novel mechanism of action that are likely to have activity as sing...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965688/ https://www.ncbi.nlm.nih.gov/pubmed/33737856 http://dx.doi.org/10.2147/BLCTT.S245191 |